No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Psychedelic Drug Developer Lykos Could Get Lifeline From Former Tesla Board Member
Atai Life Sciences Names Dr. Srinivas Rao Sole CEO
ATAI Life Sciences Revamps Leadership Amid Clinical Trials
ATAI Life Sciences: Kevin Craig Named Chief Medical Officer >ATAI
Atai Life Sciences Names Srinivas Rao as Sole CEO
Press Release: Atai Life Sciences Announces Key Leadership Appointments as It Advances Its Pipeline of Novel Psychedelic Therapeutics for Mental Health